Swiss National Bank Purchases 6,500 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Swiss National Bank lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,287,187 shares of the company's stock after purchasing an additional 6,500 shares during the quarter. Swiss National Bank owned about 0.28% of GE HealthCare Technologies worth $120,802,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Pathway Financial Advisers LLC purchased a new position in GE HealthCare Technologies during the first quarter valued at approximately $25,000. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after purchasing an additional 251 shares during the period. Fred Alger Management LLC acquired a new position in GE HealthCare Technologies during the second quarter valued at $26,000. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies during the third quarter valued at $26,000. Finally, Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies in the third quarter worth about $26,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.27% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on GEHC. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a "neutral" rating and a $90.00 target price for the company. Stifel Nicolaus lifted their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research report on Monday, September 30th. Evercore ISI increased their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 1st. Redburn Atlantic raised GE HealthCare Technologies to a "strong-buy" rating in a research report on Thursday, August 1st. Finally, BTIG Research upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $94.36.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded up $0.20 on Tuesday, reaching $82.92. 1,321,724 shares of the stock were exchanged, compared to its average volume of 3,039,822. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 1-year low of $66.39 and a 1-year high of $94.55. The firm has a market capitalization of $37.88 billion, a PE ratio of 22.73, a PEG ratio of 2.93 and a beta of 1.24. The business has a fifty day moving average price of $88.65 and a two-hundred day moving average price of $83.55.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same period in the previous year, the company posted $0.99 EPS. GE HealthCare Technologies's revenue for the quarter was up .9% on a year-over-year basis. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.03 per share. The ex-dividend date was Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies's dividend payout ratio is presently 3.30%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.